![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 15, Issue 2, 688-695, February 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Misaki Marine Biological Station, University of Tokyo, Misaki, Miura, Kanagawa 238-0225, Japan;
Department of Molecular and Cell Biology, University of California, Berkeley, California 94720-3200
Submitted June 23, 2003;
Revised September 4, 2003;
Accepted October 15, 2003
Monitoring Editor: Thomas Pollard
 |
ABSTRACT |
|---|
 TOP ABSTRACT INTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
|
INTRODUCTION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
; Berg et al., 2001). Conventional nonmuscle myosin II is comprised of two genetically distinct isoforms referred to as myosin IIA and IIB (Simons et al., 1991). Different isoforms of myosin II localize differently within individual cells, and these different distributions in the cell suggest that the two proteins have some important functional differences (Maupin et al., 1994; Rochlin et al., 1995; Kelley et al., 1997). In nonmuscle cells, myosin II has diverse functions including cytoplasmic contractility (Condeelis and Taylor, 1977), cytokinesis (DeLozanne and Spudich, 1987; Knecht and Loomis, 1987), capping of cell-surface components (Pasternak et al., 1989), polarization of cell locomotion (Wessels et al., 1988), and neurite outgrowth (Wylie et al., 1998; Wylie and Chantler, 2001). Myosin II is also suggested to be involved in membrane trafficking within the cell. It has been proposed that myosin IIB is involved in exocytosis, because microinjection of polyclonal antibody against myosin IIB suppressed neurotransmitter release (Mochida et al., 1994; Mochida, 1995). Although it has not been clear how many populations of vesicles bud off the trans-Golgi network (TGN), the p200/myosin II protein, analogous to nonmuscle myosin IIA heavy chain, has been reported to be on a specific subset of TGN-derived vesicles (Narula et al., 1992; Narula and Stow, 1995; Ikonen et al., 1997; Musch et al., 1997; Heimann et al., 1999). However, there are conflicting reports about whether p200/myosin II is an essential participant in the vesicle budding reaction (Musch et al., 1997; Simon et al., 1998). It has also been proposed that unconventional myosins type I, V, VI, and VII, are involved in membrane trafficking (Tuxworth and Titus, 2000).
The disruption of cell plasma membranes frequently occurs in many animal tissues, and cells survive these disruptions by restoring the integrity of the plasma membrane (McNeil and Steinhardt, 1997; McNeil and Terasaki, 2001). Small disruptions on the order of 1 µm evoke the calcium-dependent exocytosis of vesicles near the wound site. This response is essential for successful membrane resealing (Steinhardt et al., 1994; Bi et al., 1995, 1997; Miyake and McNeil, 1995; Togo et al., 1999; Reddy et al., 2001). Exocytosis promotes resealing by decreasing membrane tension (Togo et al., 2000). Vesicles forming exocytotic figures required for membrane resealing were selectively blocked by inhibitors of kinesin and myosin motors in a two-step process in sea urchin embryos (Bi et al., 1997). In Swiss 3T3 fibroblasts, it had been previously shown that inhibition of kinesin motor activity inhibited membrane resealing (Steinhardt et al., 1994). Furthermore, disruption of cortical actin filaments by cytochalasin D inhibited wound-induced exocytosis in 3T3 cells (Togo et al., 1999), suggesting that myosin motor activity is involved in wound-induced exocytosis. Recently, we found that a second membrane disruption at the same surface site as the initial wound resealed more quickly than the initial wound, and the BFA sensitivity of the increased rate of resealing at the second wound suggested that this facilitated response required new TGN-derived vesicles (Togo et al., 1999, 2003).
The aim of the present study was to further define which myosins are involved in membrane resealing and facilitation of membrane resealing in Swiss 3T3 fibroblasts. We applied the antisense technique to knockdown nonmuscle myosin IIA and IIB in 3T3 cells and also investigated characteristics of membrane resealing of COS-7 cells, which are missing nonmuscle myosin IIA (Tullio et al., 1997), and S91 cells, a mutant cell line lacking myosin Va (Wu et al., 1997).
|
MATERIALS AND METHODS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
Cells for experiments were plated on cover glass-inserted plastic dishes (35 x 10 mm) and were grown for 1-2 d before use. During wound experiments, the cells were maintained in 1.8 mM Ca2+ Ringer's solution. Ca2+-free Ringer's solution contained 138 mM NaCl, 2.7 mM KCl, 1.06 mM MgCl2, 5.6 mM D-glucose, and 12.4 mM HEPES (pH 7.25). A stock solution of 100 mM CaCl2 was used to adjust the concentration of Ca2+.
Treatment of Cells with Antisense Oligonucleotides
Phosphorothioate-modified oligonucleotides and fluorescein-labeled phosphorothioate-modified oligonucleotides were purchased from Integrated DNA Technologies (Coralville, IA) and Proligo Japan (Kyoto, Japan). The antisense sequence was based on the start codon and additional downstream bases of mRNA sequences of rat myosin IIA and mouse myosin IIB (accession numbers, U31463
[GenBank]
and U34303
[GenBank]
, respectively). Scrambled sequences of the antisense were used for control experiments. The antisense and scrambled sequences of myosin IIA were 5'-tgcagcctgctgggccatg-3' and 5'-ccacgtgctgcgagtgtgc-3', respectively. The antisense and scrambled sequences of myosin IIB were 5'-tccagttctctgggccatt-3' and 5'-ttactctcgcagtcggtct-3', respectively.
3T3 cells (typically 50% confluent in cover glass inserted Petri dishes) were washed once with DMEM and incubated with DMEM containing 1 µM oligonucleotide and 10 µg/ml Lipofectin (Invitrogen) for 6 h at 36°C. Culture medium was then replaced with DMEM containing 2% FBS and 1 µM oligonucleotides and further incubated at 36°C for 42 h.
Western Blotting
For analysis of protein expression of myosin IIA and IIB, cells were washed twice with PBS and lysed in lysis buffer. Lysis buffer consisted of 20 mM Tris (pH 7.5), 1.2% Triton X-100, 0.1% 2-mercaptoethanol, 500 µM AEBSF, 150 nM aprotinin, 1 µM E-64, 0.5 mM EDTA, and 1 µM leupeptin. The cell lysates were boiled for 2 min in SDS-PAGE sample buffer, and equivalent amounts of protein were separated on an 8% SDS-polyacrylamide gel and electrophoretically transferred to nitrocellulose membrane. Myosin antibodies were obtained from Covance Research Products (Denver, PA): polyclonal antibody against nonmuscle myosin II heavy chain isoform had species reactivity to human, rodent, and bovine myosin IIA. This antibody was raised against the peptide GKADGAEAKPAE corresponding to the C-terminus of human nonmuscle myosin heavy chain isoform A (MHC-A). Polyclonal antibody against nonmuscle myosin II heavy chain isoform B had species reactivity to human and rodent myosin IIB. This antibody was raised against the peptide SDVNETQPPQSE corresponding to the C-terminus of human nonmuscle myosin heavy chain isoform B (MHC-B). Each antibody recognized a single band (200 kDa) in 3T3 cells by Western blot. The membrane was incubated for 1 h with blocking solution (TBS, pH 7.6, 5% nonfat dried milk, 0.1% Tween-20) and further incubated for 1 h in blocking solution containing primary antibodies with following dilutions: myosin IIA (lot 130944001 and 135025001), 1/500; myosin IIB (lot 139019002), 1/1000; and actin, 1/5000. The mAb used against actin was obtained from Calbiochem (San Diego, CA). After washing with TBS (pH 7.6) containing 0.1% Tween-20, the membranes were incubated with horseradish peroxidase-conjugated secondary antibodies (Amersham Biosciences, Piscataway, NJ) for 1 h. Immunoreactive bands were detected by ECL Western blotting analysis reagents (Amersham Biosciences) and exposed to chemiluminescence film (Hyperfilm ECL; Amersham Biosciences).
Immunofluorescence Staining
3T3 cells were treated with antisense and scrambled oligos for myosin IIA and IIB as described above. They were fixed with 4% formaldehyde for 30 min, permeabilized with 0.1% Triton X-100 for 5 min, and stained with antibodies against nonmuscle myosin IIA, IIB, (Covance Research Products, described above) and a monoclonal anti-Golgi 58K protein from mouse that detects a peripheral Golgi membrane protein (Sigma, St. Louis, MO); rhodamine-conjugated goat anti-rabbit IgG and fluorescein-conjugated goat anti-mouse IgG (Molecular Probes, Eugene, OR) were used for detection. Staining patterns were analyzed by fluorescence microscope (DMRBE, Leica, Exton, PA) and SPOT RT camera (Diagnostic Instruments, Sterling Heights, MI). Exposure time and gain level of the camera remained constant between control (scrambled oligo) and antisense-treated cells.
Analysis of Exocytosis by FM 1-43 Destaining
3T3 cells were incubated with fresh culture medium containing 4 µM FM 1-43 (Molecular Probes) overnight. Each dish was washed with 1.8 mM Ca2+ Ringer's solution just before the experiment. Acquisition of fluorescent images was performed using a SIT68 video camera (MTI, Michigan City, IN) linked to a Zeiss IM-35 inverted microscope (Thornwood, NY). FM 1-43 fluorescence was excited at 495 nm. Images were digitized by a Digidata 2000 AD board (Axon Instruments, Union City, CA), and were acquired at 4-s intervals by averaging four frames for each image. All processes were controlled by Axon Imaging Workbench (Axon Instruments). Cells were wounded by the same system as for the resealing assay. Changes of local fluorescent intensity were localized to the area around the wound, and the change in FM 1-43 fluorescence in a circular region around the wound site (5-µm diameter) was analyzed.
Membrane Resealing Assay
Membrane resealing was monitored by measuring emission fluorescence of the calcium sensitive dye fura-2. Fura-2 was introduced into the cells by AM-ester loading. Fura-2 AM (Molecular Probes), 10 mM in DMSO as a stock, was mixed with same volume of Pluronic F-127 (25% wt/wt in DMSO) before dilution to a final loading concentration of 5 µM in 1.8 mM Ca2+ Ringer's solution containing 8% FBS for 3T3 cells or in DMEM containing 10% FBS for COS-7 and CV-1 cells. Fura-2 AM was loaded at room temperature (25°C, 3T3) or 37°C (COS-7, CV-1) for 1 h and then washed with Ringer's solution containing 1.8 mM Ca2+.
For tests of membrane resealing, fura-2-loaded cells were wounded with a glass needle using an Eppendorf 5242 microinjector and 5170 micromanipulator (Brinkmann Instruments, Westbury, NY) mounted on a Zeiss IM-35 inverted microscope, and fura-2 fluorescence was monitored. The time setting for wound was 0.3 s. All wound experiments were performed at 25°C. A persistent decrease of 357-nm excited fluorescent intensity (as an indicator of dye loss) together with a persistent increase of the ratio of fluorescent intensity excited by 385/357-nm light (as an indicator of increasing intracellular Ca2+ concentration) indicated resealing failure. A transient decrease of 357-nm excited fluorescent intensity indicated successful resealing. The interval between wound and when the fluorescent intensity reached a constant value was defined as resealing time. Because the dye leaked out completely when disruption of the plasma membrane did not reseal, loading of fura-2 at 37°C into COS-7 and CV-1 cells did not result in compartmentalization of the dye.
|
RESULTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
|
Wound-induced Exocytosis Is Significantly Decreased by IIB Antisense Treatment But Not by IIA Antisense Treatment
We first investigated whether the treatment with antisense oligonucleotide of nonmuscle myosin IIs inhibited exocytosis after wounding. To observe exocytosis accompanying microdisruptions, the fluorescent dye FM 1-43 was pre-loaded by endocytosis during an overnight incubation. FM 1-43 intercalates into the outer leaflet of lipid bilayers and is much more fluorescent in hydrophobic than in hydrophilic environments (Cochilla et al., 1999). When cells are incubated with the dye and later washed, dye remaining in the plasma membrane rapidly diffuses away, leaving only dye that is trapped in the endocytosed vesicles. Subsequent delivery of the labeled vesicles into the plasma membrane by exocytosis allows diffusion of the dye into the external media and results in a loss of cellular fluorescence near the wound site. Treatment with a IIB scramble antisense nucleotide gave normal levels of wound-induced FM1-3 destaining of 4.4 ± 0.61% (n = 16), whereas treatment with antisense IIB reduced destaining to 2.2 ± 0.34% (n = 15; Figure 2). Treatment with scramble and antisense to IIA showed no effect on exocytosis, scramble destaining, 4.7 ± 0.46% (n = 7); and antisense destaining 4.3 ± 0.47% (n = 6; Figure 2).
|
Antisense Oligonucleotide of Nonmuscle Myosin IIB Inhibits Membrane Resealing at an Initial Wound
To investigate the role of nonmuscle myosins IIA and IIB in membrane resealing, 3T3 cells were treated either with antisense oligonucleotide of nonmuscle myosin IIA or IIB. These cells were loaded with fura-2 AM, and changes of fura-2 fluorescence were monitored during wounding experiments. As described previously (Steinhardt et al., 1994), a membrane disruption (arrows in Figure 3) was indicated by sharp rise in the emission ratio of fura-2 excited at 385 and 357 nm, and the loss of the dye resulted in a decrease in the fluorescent intensity excited at 357 nm. When the cell resealed, the decrease in fluorescent intensity stopped (bar in Figure 3). To compare timing of membrane resealing in each condition, the resealing rate was defined as the inverse of the resealing time in seconds. For cells that failed to reseal, the rate was defined as zero. When the cells were treated with antisense or scrambled oligonucleotide of myosin IIA, the average resealing rate at an initial wound was 0.066 ± 0.013 (n = 30) or 0.076 ± 0.014 (n = 28), respectively (Table 1), and there was no significant difference between these values (p = 0.5983, Student's t test). These resealing rates were statistically identical to the value of untreated cells reported previously (Togo et al., 1999, 2000). Therefore, these results indicate that membrane resealing at the initial wound was not affected by the treatments with IIA antisense.
|
|
When the cells were treated with antisense oligonucleotide of myosin IIB (Figure 3A), the percentage of successful membrane resealing was 46.7%, and the average resealing rate at these initial wounds was 0.029 ± 0.011 (n = 30; Table 1). On the other hand, the percentage of resealing was 84.2%, and the resealing rate was 0.069 ± 0.011 (n = 19) when the cells were treated with scrambled oligonucleotide (Table 1; Figure 3B). This resealing rate for scrambled oligonucleotide was statistically identical to the value of untreated cells reported previously (Togo et al., 1999, 2000). These results indicate that nonmuscle myosin IIB is needed for membrane resealing at initial wounds in 3T3 fibroblasts.
Antisense Oligonucleotide of Nonmuscle Myosin IIA Inhibits Facilitation of Membrane Resealing But Not the Resealing of an Initial Wound
To test the role of nonmuscle myosin IIA in facilitated response, 3T3 cells were treated with antisense or scrambled oligonucleotides of nonmuscle myosin IIA and wounded twice. Contrary to the initial wound, the facilitated resealings at second wounds were suppressed in the majority of the antisense-treated cells; resealings at the second wounds were same or slower than at the initial wounds (Figure 4, Table 1). A typical fura-2 recording example is shown in Figure 4A. However, scrambled oligonucleotide did not have any inhibitory effect on the facilitated response of membrane resealing (Figure 4B). Figure 4C summarizes the results of the double-wound experiments. The majority of data points from antisense-treated cells fell below the diagonal, indicating that the second resealing rate was lower than the first rate. Average ratio of first and second resealing rate (2nd/1st) of control (scrambled oligonucleotidestreated) cells was 1.97 ± 0.47 (n = 21), whereas the ratio of antisense-treated cells was 0.80 ± 0.25 (n = 25; Figure 4D). These results indicate that nonmuscle myosin IIA is required for facilitation of membrane resealing at repeated wounds.
|
COS-7 Cells Do Not Show a Facilitated Response during Repeated Wounds
COS-7, a monkey kidney cell line, was established from the CV-1 cell line (Gluzman, 1981) and lacks nonmuscle myosin IIA (Tullio et al., 1997). Western blotting analysis confirmed this, whereas CV-1 cells do have nonmuscle myosin IIA (Figure 5A). To further check whether nonmuscle myosin IIA is required for facilitated membrane resealing at repeated wounds, fura-2-loaded COS-7 and CV-1 cells were wounded twice, and initial and second resealing rates were compared. The results of double-wound experiments are summarized in Figure 5, B and C, where initial rates are plotted on the X axis and second rates on the Y. Points above the diagonal graphically show faciliatation. The majority of data points from COS-7 cells were scattered around the diagonal (Figure 5B), and there was no significant difference in the rates of resealing to first and second wounds, 0.08 ± 0.01 (n = 17) and 0.08 ± 0.01 (n = 17), respectively. On the other hand, comparisons of the resealing rates to first and second wounds in CV-1 cells, initial 0.08 ± 0.02 (n = 13); second 0.15 ± 0.02 (n = 13), clearly showed facilitation (Figure 5C). These results indicate that COS-7 cells do not have the facilitated response of membrane resealing and suggest that the facilitated resealing at repeated wounds requires nonmuscle myosin IIA.
|
S91 Cells Show Normal Membrane Resealing and Facilitated Response
To determine whether myosin Va is involved in membrane resealing, we investigated the characteristics of membrane resealing in S91 melanoma cells. This cell line was originally derived from a tumor carried by a mouse from the inbred strain DBA/2J, which is homozygous dv/dv (Jenkins et al., 1981) and is lacking myosin Va (Wu et al., 1997).
When the cells were wounded, the average resealing rate at an initial wound was 0.069 ± 0.011 (n = 22), and the percentage of membrane resealing was 81.8%. This indicated that membrane resealing at the initial wound was normal in S91 cells.
We next investigated the resealing rates to repeated wounds in S91 cells. S91 cells showed clear evidence of facilitated responses: initial rate 0.08 ± 0.01 (n = 18), second rate 0.13 ± 0.02 (n = 18). The majority of data points plotted above the diagonal, indicating that the second resealing rate was faster than the first rate (Figure 5D). These results suggest that myosin Va is not involved in vesicle generation, transport, and exocytosis during membrane resealing in S91 cells.
Finally, Figure 5E summarizes the significant of differences between first and second rates of resealing in all three cell lines, confirming a role for myosin IIA in facilitated cell membrane responses and ruling out a role for myosin Va, at least in S91 cells.
Distribution of Nonmuscle Myosins IIA and IIB
To investigate the distributions of nonmuscle myosin IIA and IIB in 3T3 cells, cells were treated with antisense and scrambled oligo nucleotides for myosin IIA and IIB, and immunostaining was carried out with the antibodies to myosin IIA and IIB together with anti-Golgi 58K protein antibody that recognizes the Golgi membrane 58-kDa protein (Bloom and Brashear, 1989). As shown in Figure 6, A and A', myosin IIA colocalizes with the 58-kDa Golgi peripheral membrane protein in an asymmetric perinuclear manner when cells were treated scrambled oligonucleotide of myosin IIA. When cells were treated with antisense oligonucleotide of myosin IIA, the amount of myosin IIA at Golgi region was decreased (Figure 6, B and B'). These results suggest that myosin IIA is enriched in the Golgi apparatus, which is consistent with the requirement for IIA in the facilitated rates of membrane repair and the need for new vesicles for repair at second wounds. Myosin IIB was abundant in the cell periphery, and stress fibers when cells were treated with scrambled oligonucleotide of myosin IIB (Figure 6C). When cells were treated with antisense oligonucleotide of myosin IIB, the amount of myosin IIB was decreased (Figure 6D), consistent with a role in trafficking just beneath the plasma membrane during exocytosis. There were no signs of "purse string" distributions of myosin IIB (Bement et al., 1999) when cells were rapidly fixed after wounding (unpublished data).
|
|
DISCUSSION |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
; Bi et al., 1995, 1997; Togo et al., 1999). In the present study, we showed that both membrane resealing and exocytosis triggered by calcium influx at the wound was suppressed by the treatment with antisense oligonucleotide of nonmuscle myosin IIB (Figures 1, 2, 3; Table 1). Myosin IIB was abundant in the cell periphery, which is consistent with a role in the transport of vesicles through the actin cortex to the plasma membrane near the disrupted site. Alternately, myosin IIB might be essential to an actin rearrangement permissive for exocytosis (Trifaro et al., 2002; Rose et al., 2003). We saw no evidence of myosin IIB "purse-string" formation. Myosin purse-strings have been shown to play a role in healing large wounds in Xenopus oocytes (Bement et al., 1999). There are previous suggestions of myosin II mediated vesicle transport. 1) Vesicles move beneath the plasma membrane using myosin motor activity in PC-12 cells (Lang et al., 2000). 2) Myosin inhibitor, butanedione monoxime (BDM), blocks the step of vesicle recruitment just before docking for Ca2+-regulated exocytosis in membrane resealing (Bi et al., 1997). 3) Myosin II is purified with vesicles (Costa et al., 1999; Miller and Sheetz, 2000). 4) It has been shown that myosin II can carry vesicles along actin filament in vitro (Sandberg et al., 2000). 5) Injection of polyclonal antibody against nonmuscle myosin IIB inhibited neurotransmitter release (Mochida et al., 1994; Mochida, 1995).
However, most evidence implicates myosin class V for a role in vesicle transport (Reck-Peterson et al., 2000; Tuxworth and Titus, 2000; Ohyama et al., 2001; Stachelek et al., 2001; Brown et al., 2002; Langford, 2002; Schott et al., 2002; Rose et al., 2003). The evidence for a role for myosin V in particular instances does not exclude a possible role for myosin type II. In fact myosin V and II can colocalize to the same vesicle (Costa et al., 1999; Miller and Sheetz, 2000). More recently myosin II has been found associated with a substantial fraction of axoplasmic organelles and is postulated to play a transport role for those organelles in axons (DeGiorgis et al., 2002), a finding that supports earlier results from antibodies (Sandberg et al., 2000). Likewise, our finding that myosin Va is not required to reseal membrane disruptions in S91 melanoma cells does not rule out that another uncharacterized myosin type V could be needed for resealing in these cells. We have no evidence on myosin Vb and the new myosin class Vc that has been recently characterized in epithelial cells (Rodriguez and Cheney, 2002).
The Role of Nonmuscle Myosin IIA in the Facilitated Response of Membrane Resealing and Vesicle Generation at Golgi
Our present study demonstrated clearly that nonmuscle myosin IIA was needed for the facilitated rates of membrane resealing of repeated wounds at the same site. Knockdown of nonmuscle myosin IIA by treatment with antisense oligonucleotide inhibited facilitation in 3T3 fibroblasts (Figures 1 and 4). COS-7 cells, which do not have nonmuscle myosin IIA, did not show facilitated response at repeated membrane disruptions, whereas facilitation of CV-1 cells, from which they were derived, was normal (Figure 5).
We have previously shown that Gö-6976, a specific inhibitor for Ca2+-dependent PKC isozymes (Martiny-Baron et al., 1993), and brefeldin A (BFA), a fungal metabolite that inhibits binding of ADP-ribosylation factor to the Golgi (Klausner et al., 1992), inhibits facilitated membrane resealing at repeated wounds in 3T3 cells (Togo et al., 1999). This inhibition of facilitated resealing and our previous studies of FM 1-43 destaining assay suggested that facilitation of membrane resealing requires exocytosis of a new vesicle pool generated via a PKC-dependent and BFA-sensitive process (Togo et al., 1999).
Therefore, both a myosin IIA-dependent and a BFA-sensitive process are required for facilitation of the membrane resealing at repeated wounds. We propose that nonmuscle myosin IIA is involved in vesicle generation at TGN at facilitated response of the membrane resealing. Several lines of evidence suggest this possibility. First, it has been reported that the p200/myosin II, analogous to nonmuscle myosin IIA heavy chain, is involved in vesicle generation at TGN in many cells (Narula et al., 1992; Narula and Stow, 1995; Ikonen et al., 1997; Musch et al., 1997; Heimann et al., 1999). Second, binding of myosin IIA to the Golgi is known to be BFA sensitive (Ikonen et al., 1997). Third, myosin II was localized by immunofluorescence in a variety of cultured cells using an antiserum that recognizes nonmuscle myosin II. In NRK cells, myosin II, detected by an antibody against chick intestinal brush border nonmuscle myosin II, localizes at the Golgi (Ikonen et al., 1997). In 3T3 cells, myosin IIA localizes at the Golgi (Heimann et al., 1999; this study).
In vitro analysis suggests that p200/myosin II is involved in a part of constitutive basolateral transport (Narula et al., 1992; Narula and Stow, 1995; Ikonen et al., 1997; Musch et al., 1997; Heimann et al., 1999). Therefore, cells may use this constitutive pathway or regulated secretion pathway to refill the vesicle pool that is depleted at initial wounds. TGN-derived vesicles can undergo Ca2+-regulated exocytosis (Maletic-Savatic and Malinow, 1998). There is a conflicting report proposing that p200/myosin II is not an essential participant in the vesicle budding reaction of constitutive secretory pathways and that the p200 antibody used in functional studies cross reacted with coatomer (Simon et al., 1998). This finding calls into question the functional evidence for myosin IIA at the TGN. However, using a different antibody we could confirm its concentration at the TGN. This confirmation of localization, together with our finding of an essential role for myosin IIA in BFA-sensitive facilitated membrane repair, suggests that myosin IIA does have a functional role in membrane trafficking at the Golgi.
|
ACKNOWLEDGMENTS |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
|
Footnotes |
|---|
Abbreviations used: BFA, brefeldin A; DMEM, Dulbecco's modified Eagle's medium; FBS, fetal bovine serum; PKC, protein kinase C; TGN, trans-Golgi network.
Corresponding author. E-mail address: rsteinha{at}socrates.berkeley.edu.
|
REFERENCES |
|---|
|
TOPABSTRACTINTRODUCTIONMATERIALS AND METHODSRESULTSDISCUSSIONACKNOWLEDGMENTSREFERENCES |
|---|
Berg, J.S., Powell, B.C., and Cheney, R.E. (2001). A millennial myosin census. Mol. Biol. Cell 12, 780-794.
Bi, G.-Q., Alderton, J.M., and Steinhardt, R.A. (1995). Calcium-regulated exocytosis is required for cell membrane resealing. J. Cell Biol. 131, 1747-1758.
Bi, G.-Q., Morris, R.L., Liao, G., Alderton, J.M., Scholey, J.M., and Steinhardt, R.A. (1997). Kinesin- and myosin-driven steps of vesicle recruitment for Ca2+-regulated exocytosis. J. Cell Biol. 138, 999-1008.
Bloom, G.S., and Brashear, T.A. (1989). A novel 58-kDa protein associates with the Golgi apparatus and microtubules. J. Biol. Chem. 264, 16083-16092.
Brown, J.R., Peacock-Villada, E.M., and Langford, G.M. (2002). Globular tail fragment of myosin-V displaces vesicle-associated motor and blocks vesicle transport in squid nerve cell extracts. Biol. Bull. 203, 210-211.
Cochilla, A.J., Angleson, J.K., and Betz, W.J. (1999). Monitoring secretory membrane with FM1-43 fluorescence. Annu. Rev. Neurosci. 22, 1-10.[CrossRef][Medline]
Condeelis, J.S., and Taylor, D.L. (1977). The contractile basis of amoeboid movement. V. The control of gelation, solation, and contraction in extracts from Dictyostelium discoideum. J. Cell Biol. 74, 901-927.
Costa, M.C.R., Mani, F., Santoro, J., W., Espreafico, E.M., and Larson, R.E. (1999). Brain myosin-V, a calmodulin-carrying myosin, binds to calmodulin-dependent protein kinase II and activates its kinase activity. J. Biol. Chem. 274, 15811-15819.
DeGiorgis, J.A., Reese, T.S., and Bearer, E.L. (2002). Association of a nonmuscle myosin II with axoplasmic organelles. Mol. Biol. Cell 13, 1046-1057.
DeLozanne, A., and Spudich, J.A. (1987). Disruption of the Dictyostelium myosin heavy chain gene by homologous recombination. Science 236, 1086-1091.
Gluzman, Y. (1981). SV40-transformed simian cells support the replication of early SV40 mutants. Cell 23, 175-182.[CrossRef][Medline]
Heimann, K., Percival, J.M., Weinbergers, R., Gunning, P., and Stow, J.L. (1999). Specific isoforms of actin-binding proteins on distinct populations of Golgi-derived vesicles. J. Biol. Chem. 274, 10743-10750.
Ikonen, E., de Almeida, J.B., Fath, K.R., Burgess, D.R., Ashman, K., Simons, K., and Stow, J.L. (1997). Myosin II is associated with Golgi membranes: identification of p200 as nonmuscle myosin II on Golgi-derived vesicles. J. Cell Sci. 110, 2155-2164.[Abstract]
Jenkins, N.A., Copeland, N.G., Taylor, B.A., and Lee, B.K. (1981). Dilute (d) coat colour mutation of DBA/J mice is associated with the site of integration of an ectropic MuLV genome. Nature 293, 370-374.[CrossRef][Medline]
Kelley, C.A., Sellers, J.R., Gard, D.L., Bui, D., Adelstein, R.S., and Baines, I.C. (1997). Xenopus nonmuscle myosin heavy chain isoforms have different sub-cellular localizations and enzymatic activities. J. Cell Biol. 134, 675-687.
Klausner, R.D., Donaldson, J.G., and Lippincott-Schwartz, J. (1992). Brefeldin A: insights into the control of membrane traffic and organelle structure. J. Cell Biol. 116, 1071-1080.
Knecht, D.A., and Loomis, W.F. (1987). Antisense RNA inactivation of myosin heavy chain gene expression in Dictyostelium discoideum. Science 236, 1081-1086.
Lang, T., Wacker, I., Wunderlich, I., Rohrbach, A., Giese, G., Soldati, T., and Almers, W. (2000). Role of actin cortex in the subplasmalemmal transport of secretory granules in PC-12 cells. Biophys. J. 78, 2863-2877.[Medline]
Langford, G.M. (2002). Myosin-v, a versatile motor for short-range vesicle transport. Traffic 3, 859-865.[CrossRef][Medline]
Maletic-Savatic, M., and Malinow, R. (1998). Calcium-evoked dendritic exocytosis in cultured hippocampal neurons. Part I: trans-Golgi network-derived organelles undergo regulated exocytosis. J. Neurosci. 18, 6803-6813.
Martiny-Baron, G., Kazanietz, M.G., Mischak, H., Blumberg, P.M., Kochs, G., Hug, H., Marme, D., and Schachtele, C. (1993). Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268, 9194-9197.
Maupin, P., Phillips, C.L., Adelstein, R.S., and Pollard, T.D. (1994). Differential localization of myosin-II isozymes in human cultured cells and blood cells. J. Cell Sci. 107, 3077-3090.[Abstract]
McNeil, P.L., and Steinhardt, R.A. (1997). Loss, restoration, and maintenance of plasma membrane integrity. J. Cell Biol. 137, 1-4.
McNeil, P.L., and Terasaki, M. (2001). Coping with the inevitable: how cells repair a torn surface membrane. Nat. Cell Biol. 3, E124-129.[CrossRef][Medline]
Miller, K.E., and Sheetz, M.P. (2000). Characterization of myosin V binding to brain vesicles. J. Biol. Chem. 275, 2598-2606.
Miyake, K., and McNeil, P.L. (1995). Vesicle accumulation and exocytosis at sites of plasma membrane disruption. J. Cell Biol. 131, 1737-1745.
Mochida, S. (1995). Role of myosin in neurotransmitter release: functional studies at synapses formed in culture. J. Physiol. Paris 89, 83-94.[CrossRef][Medline]
Mochida, S., Kobayashi, H., Matsuda, Y., Yuda, Y., Muramoto, K., and Nonomura, Y. (1994). Myosin II is involved in transmitter release at synapses formed between rat sympathetic neurons in culture. Neuron 13, 1131-1142.[CrossRef][Medline]
Musch, A., Cohen, D., and Rodriguez-Boulan, E. (1997). Myosin II is involved in the production of constitutive transport vesicles from the TGN. J. Cell Biol. 138, 291-306.
Narula, N., McMorrow, I., Plopper, G., Doherty, J., Matlin, K.S., Burke, B., and Stow, J.L. (1992). Identification of a 200-kD brefeldin-sensitive protein on Golgi membranes. J. Cell Biol. 117, 27-38.
Narula, N., and Stow, J.L. (1995). Distinct coated vesicles labeled for p200 bud from trans-Golgi network membranes. Proc. Natl. Acad. Sci. USA 92, 2874-2878.
Ohyama, A., Komiya, Y., and Igarashi, M. (2001). Globular tail of myosin-V is bound to vamp/synaptobrevin. Biochem. Biophys. Res. Commun. 280, 988-991.[CrossRef][Medline]
Pasternak, C., Spudich, J.A., and Elson, E.L. (1989). Capping of surface receptors and concomitant cortical tension are generated by conventional myosin. Nature 341, 549-551.[CrossRef][Medline]
Reck-Peterson, S.L., Provance, D.W., Jr., Mooseker, M.S., and Mercer, J.A. (2000). Class V myosins. Biochim. Biophys. Acta 1496, 36-51.[Medline]
Reddy, A., Caler, E.V., and Andrews, N.W. (2001). Plasma membrane repair is mediated by Ca2+-regulated exocytosis of lysosomes. Cell 106, 157-169.[CrossRef][Medline]
Rochlin, M.W., Itoh, K., Adelstein, R.S., and Bridgman, P.C. (1995). Localization of myosin II A and B isoforms in cultured neurons. J. Cell Sci. 108, 3661-3670.[Abstract]
Rodriguez, O.C., and Cheney, R.E. (2002). Human myosin-Vc is a novel class V myosin expressed in epithelial cells. J. Cell Sci. 115, 991-1004.
Rose, S.D., Lejen, T., Casaletti, L., Larson, R.E., Pene, T.D., and Trifaro, J.M. (2003). Myosins II and V in chromaffin cells: myosin V is a chromaffin vesicle molecular motor involved in secretion. J. Neurochem. 85, 287-298.[Medline]
Sandberg, L., Stafford, P., and Langford, G.M. (2000). Effects of myosin-II antibody on actin-dependent vesicle transport in extracts of clam oocytes. Biol. Bull. 199, 202-203.[Medline]
Schott, D.H., Collins, R.N., and Bretscher, A. (2002). Secretory vesicle transport velocity in living cells depends on the myosin-V lever arm length. J. Cell Biol. 156, 35-39.
Sellers, J.R. (2000). Myosins: a diverse superfamily. Biochim. Biophys. Acta 1496, 3-22.[Medline]
Simon, J.-P., Shen, T.-H., Ivanov, I.E., Gravotta, D., Morimoto, T., Adesnik, M., and Sabatini, D.D. (1998). Coatomer, but not P200/myosin II, is required for the in vitro formation of trans-Golgi network-derived vesicles containing the envelope glycoprotein of vesicular stomatitis virus. Proc. Natl. Acad. Sci. USA 95, 1073-1078.
Simons, M., Wang, M., McBride, O.W., Kawamoto, S., Yamasaki, K., Gdula, D., Adelstein, R.S., and Weir, L. (1991). Human nonmuscle myosin heavy chains are encoded by two genes located on different chromosomes. Circ. Res. 69, 530-539.
Stachelek, S.J., Tuft, R.A., Lifschitz, L.M., Leonard, D.M., Farwell, A.P., and Leonard, J.L. (2001). Real-time visualization of processive myosin 5a-mediated vesicle movement in living astrocytes. J. Biol. Chem. 276, 35652-35659.
Steinhardt, R.A., Bi, G.-Q., and Alderton, J.M. (1994). Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science 263, 390-393.
Togo, T., Alderton, J.M., Bi, G.-Q., and Steinhardt, R.A. (1999). The mechanism of facilitated cell membrane resealing. J. Cell Sci. 112, 719-731.[Abstract]
Togo, T., Alderton, J.M., and Steinhardt, R.A. (2003). Long-term potentiation of exocytosis and cell membrane repair in fibroblasts. Mol. Biol. Cell 14, 93-106.
Togo, T., Krasieva, T.B., and Steinhardt, R.A. (2000). A decrease in membrane tension precedes successful cell membrane repair. Mol. Biol. Cell 11, 4339-4346.
Trifaro, J.M., Lejen, T., Rose, S.D., Pene, T.D., Barkar, N.D., and Seward, E.P. (2002). Pathways that control cortical F-actin dynamics during secretion. Neurochem. Res. 27, 1371-1385.[CrossRef][Medline]
Tullio, A.N., Accili, D., Ferrans, V.J., Yu, Z.-X., Takeda, K., Grinberg, A., Westphal, H., Preston, Y.A., and Adelstein, R.S. (1997). Nonmuscle myosin II-B is required for normal development of the mouse heart. Proc. Natl. Acad. Sci. USA 94, 12407-12412.
Tuxworth, R.I., and Titus, M.A. (2000). Unconventional myosins: anchors in the membrane traffic relay. Traffic 1, 11-18.[CrossRef][Medline]
Wessels, D., Soll, D.R., Knecht, D., Loomis, W.F., DeLozanne, A., and Spudich, J. (1988). Cell motility and chemotaxis in Dictyostelium discoideum amebae lacking myosin heavy chain. Dev. Biol. 128, 164-177.[CrossRef][Medline]
Wu, X., Bowers, B., Wei, Q., Kocher, B., and Hammer, J.A., III. (1997). Myosin V associates with melanosomes in mouse melanocytes: evidence that myosin V is an organelle motor. J. Cell Sci. 110, 847-859.[Abstract]
Wylie, S.R., and Chantler, P.D. (2001). Separate but linked functions of conventional myosins modulate adhesion and neurite outgrowth. Nat. Cell Biol. 3, 88-92.[CrossRef][Medline]
Wylie, S.R., Wu, P.-J., Patel, H., and Chantler, P.D. (1998). A conventional myosin motor drives neurite outgrowth. Proc. Natl. Acad. Sci. USA 95, 12967-12972.
This article has been cited by other articles:
|
|
 |
|
  B. J. Gu, C. Rathsam, L. Stokes, A. B. McGeachie, and J. S. Wiley Extracellular ATP dissociates nonmuscle myosin from P2X7 complex: this dissociation regulates P2X7 pore formation Am J Physiol Cell Physiol, August 1, 2009; 297(2): C430 - C439. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Babbin, S. Koch, M. Bachar, M.-A. Conti, C. A. Parkos, R. S. Adelstein, A. Nusrat, and A. I. Ivanov Non-Muscle Myosin IIA Differentially Regulates Intestinal Epithelial Cell Restitution and Matrix Invasion Am. J. Pathol., February 1, 2009; 174(2): 436 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Crowley, T. C. Smith, Z. Fang, N. Takizawa, and E. J. Luna Supervillin Reorganizes the Actin Cytoskeleton and Increases Invadopodial Efficiency Mol. Biol. Cell, February 1, 2009; 20(3): 948 - 962. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Cao, C. Li, J. N. Higginbotham, J. L. Franklin, D. L. Tabb, R. Graves-Deal, S. Hill, K. Cheek, W. G. Jerome, L. A. Lapierre, et al. Use of Fluorescence-activated Vesicle Sorting for Isolation of Naked2-associated, Basolaterally Targeted Exocytic Vesicles for Proteomics Analysis Mol. Cell. Proteomics, September 1, 2008; 7(9): 1651 - 1667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Wylie and P. D. Chantler Myosin IIC: A Third Molecular Motor Driving Neuronal Dynamics Mol. Biol. Cell, September 1, 2008; 19(9): 3956 - 3968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Solinet and M. L. Vitale Isoform B of myosin II heavy chain mediates actomyosin contractility during TNF{alpha}-induced apoptosis J. Cell Sci., May 15, 2008; 121(10): 1681 - 1692. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Takizawa, R. Ikebe, M. Ikebe, and E. J. Luna Supervillin slows cell spreading by facilitating myosin II activation at the cell periphery J. Cell Sci., November 1, 2007; 120(21): 3792 - 3803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schietroma, H.-Y. Yu, M. C. Wagner, J. A. Umbach, W. M. Bement, and C. B. Gundersen A Role for Myosin 1e in Cortical Granule Exocytosis in Xenopus Oocytes J. Biol. Chem., October 5, 2007; 282(40): 29504 - 29513. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Andzelm, X. Chen, K. Krzewski, J. S. Orange, and J. L. Strominger Myosin IIA is required for cytolytic granule exocytosis in human NK cells J. Exp. Med., October 1, 2007; 204(10): 2285 - 2291. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Boucrot and T. Kirchhausen Endosomal recycling controls plasma membrane area during mitosis PNAS, May 8, 2007; 104(19): 7939 - 7944. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rey, A. Valenzuela-Fernandez, A. Urzainqui, M. Yanez-Mo, M. Perez-Martinez, P. Penela, F. Mayor Jr, and F. Sanchez-Madrid Myosin IIA is involved in the endocytosis of CXCR4 induced by SDF-1{alpha} J. Cell Sci., March 15, 2007; 120(6): 1126 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Betapudi, L. S. Licate, and T. T. Egelhoff Distinct Roles of Nonmuscle Myosin II Isoforms in the Regulation of MDA-MB-231 Breast Cancer Cell Spreading and Migration. Cancer Res., May 1, 2006; 66(9): 4725 - 4733. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Matson, S. Markoulaki, and T. Ducibella Antagonists of Myosin Light Chain Kinase and of Myosin II Inhibit Specific Events of Egg Activation in Fertilized Mouse Eggs Biol Reprod, January 1, 2006; 74(1): 169 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-H. Yang, J. Szeliga, J. Jordan, S. Faske, Z. Sever-Chroneos, B. Dorsett, R. E. Christian, R. E. Settlage, J. Shabanowitz, D. F. Hunt, et al. Identification of the Surfactant Protein A Receptor 210 as the Unconventional Myosin 18A J. Biol. Chem., October 14, 2005; 280(41): 34447 - 34457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. W. Andrews Response to "Shaky Ground for Lysosome-Dependent Membrane Repair" Sci. Signal., October 4, 2005; 2005(304): lc2 - lc2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Shewan, M. Maddugoda, A. Kraemer, S. J. Stehbens, S. Verma, E. M. Kovacs, and A. S. Yap Myosin 2 Is a Key Rho Kinase Target Necessary for the Local Concentration of E-Cadherin at Cell-Cell Contacts Mol. Biol. Cell, October 1, 2005; 16(10): 4531 - 4542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Krendel and M. S. Mooseker Myosins: Tails (and Heads) of Functional Diversity Physiology, August 1, 2005; 20(4): 239 - 251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. E. Vlahakis and R. D. Hubmayr Cellular Stress Failure in Ventilator-injured Lungs Am. J. Respir. Crit. Care Med., June 15, 2005; 171(12): 1328 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. A. Benink and W. M. Bement Concentric zones of active RhoA and Cdc42 around single cell wounds J. Cell Biol., January 31, 2005; 168(3): 429 - 439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Togo Long-term Potentiation of Wound-induced Exocytosis and Plasma Membrane Repair Is Dependant on cAMP-response Element-mediated Transcription via a Protein Kinase C- and p38 MAPK-dependent Pathway J. Biol. Chem., October 22, 2004; 279(43): 44996 - 45003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. I. Ivanov, I. C. McCall, C. A. Parkos, and A. Nusrat Role for Actin Filament Turnover and a Myosin II Motor in Cytoskeleton-driven Disassembly of the Epithelial Apical Junctional Complex Mol. Biol. Cell, June 1, 2004; 15(6): 2639 - 2651. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Klezovitch, T. E. Fernandez, S. J. Tapscott, and V. Vasioukhin Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice Genes & Dev., March 1, 2004; 18(5): 559 - 571. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
